- Home
- LENZ vs MFA Comparison
LENZ vs MFA Comparison
Compare LENZ & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- MFA
- Stock Information
- Founded
- LENZ 2019
- MFA 1997
- Country
- LENZ United States
- MFA United States
- Employees
- LENZ N/A
- MFA N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- MFA Real Estate Investment Trusts
- Sector
- LENZ Health Care
- MFA Real Estate
- Exchange
- LENZ Nasdaq
- MFA Nasdaq
- Market Cap
- LENZ 886.0M
- MFA 980.3M
- IPO Year
- LENZ 2021
- MFA N/A
- Fundamental
- Price
- LENZ $33.53
- MFA $9.46
- Analyst Decision
- LENZ Strong Buy
- MFA Buy
- Analyst Count
- LENZ 5
- MFA 9
- Target Price
- LENZ $41.80
- MFA $11.75
- AVG Volume (30 Days)
- LENZ 330.7K
- MFA 1.3M
- Earning Date
- LENZ 05-07-2025
- MFA 08-06-2025
- Dividend Yield
- LENZ N/A
- MFA 15.29%
- EPS Growth
- LENZ N/A
- MFA N/A
- EPS
- LENZ N/A
- MFA 0.99
- Revenue
- LENZ N/A
- MFA $292,245,000.00
- Revenue This Year
- LENZ N/A
- MFA N/A
- Revenue Next Year
- LENZ $544.90
- MFA $12.27
- P/E Ratio
- LENZ N/A
- MFA $9.51
- Revenue Growth
- LENZ N/A
- MFA 52.95
- 52 Week Low
- LENZ $16.54
- MFA $7.85
- 52 Week High
- LENZ $38.93
- MFA $13.45
- Technical
- Relative Strength Index (RSI)
- LENZ 54.45
- MFA 45.48
- Support Level
- LENZ $32.72
- MFA $9.14
- Resistance Level
- LENZ $35.87
- MFA $9.44
- Average True Range (ATR)
- LENZ 1.97
- MFA 0.16
- MACD
- LENZ -0.12
- MFA -0.03
- Stochastic Oscillator
- LENZ 46.30
- MFA 29.10
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.